Xvivo Perfusion AB (publ) - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
XVIPY Over the counter 3850 www.xvivogroup.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xvivo Perfusion AB (publ)

What New Catalysts Are Reshaping the Narrative for Xvivo Perfusion? - Dec 3rd, 2025 7:11 pm
Why The Narrative Around Xvivo Perfusion Is Shifting With Recent Analyst Developments - Nov 19th, 2025 11:15 am
Interim Report January-September 2025 - Oct 22nd, 2025 11:50 pm
Conference Call on Interim Report July-September 2025 - Oct 13th, 2025 11:15 am
How Recent Developments Are Shaping the Xvivo Perfusion Growth Story - Oct 8th, 2025 9:14 am
Nomination Committee of XVIVO Perfusion AB (publ) - Sep 5th, 2025 6:45 am
Organ Preservation Market Outlook Report 2025-2030: University of Wisconsin Solution Leads the Way in Organ Preservation with Largest Market Share - Aug 18th, 2025 2:26 am
Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation - Jul 28th, 2025 2:30 pm
First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device - Jul 21st, 2025 1:20 am
Interim Report January-June 2025 - Jul 10th, 2025 11:50 pm
Conference Call on Interim Report April-June 2025 - Jul 10th, 2025 8:40 am
Exploring European Undervalued Small Caps With Insider Action In June 2025 - Jun 24th, 2025 11:39 pm
XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market - Jun 13th, 2025 6:05 am
Discover 3 European Stocks That May Be Trading Below Their Estimated Value - Jun 5th, 2025 4:37 am
Exploring 3 Top Undervalued European Small Caps With Recent Insider Action - Apr 30th, 2025 11:39 pm
XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston - Apr 29th, 2025 12:20 am
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ) - Apr 25th, 2025 6:30 am
Interim Report January-March 2025 - Apr 23rd, 2025 11:50 pm
3 European Stocks Estimated To Be Trading Below Intrinsic Value By Up To 40.7% - Apr 21st, 2025 11:41 pm
Conference Call on Interim Report January-March 2025 - Apr 15th, 2025 12:30 pm